AstraZeneca resumes Phase 3 COVID-19 vaccine trial in the U.K.

Elvera Bartels

AstraZeneca, one particular of the pharmaceutical firms creating a COVID-19 vaccine, introduced in excess of the weekend that medical trials in the U.K. have resumed.

The corporation got the inexperienced light-weight from the Medicines Health and fitness Regulatory Authority that continuing to test the vaccine was protected.


Previous 7 days, AstraZeneca put its Section 3 demo on maintain soon after a participant grew to become unwell. This was a regimen motion to make sure the protection and integrity of the demo, AstraZeneca stated in its assertion.

The “unexplained health issues” triggered an impartial evaluate of the U.K., in which a panel of professionals decided that the trials were protected to resume.

AstraZeneca did not launch facts about the participant’s health issues. Nevertheless, all demo investigators, volunteers and medical registries will be up to date with relevant wellness facts, AstraZeneca stated.

THE Greater Craze

The race to produce

Read More